Geneva [Switzerland], Aug 3 (ANI): A number of coronavirus vaccines are now in phase three of clinical trials but "there's no silver bullet at the moment and there might never be," Tedros Adhanom Ghebreyesus, World Health Organisation Director-General said on Monday.
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said.
Dublin [Ireland], August 2 (ANI): A new study highlights that fitness may be a more important clinical endpoint for improvement in patients with fatty liver diseases during exercise trials, rather than weight loss.
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Washington D.C. [US], July 31 (Sputnik/ANI): The United States vaccinated several hundred volunteers during the first days of two Phase 3 COVID-19 vaccine trials, senior administration official told reporters.
New Delhi [India], July 30 (ANI): In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and Chin
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
New Delhi [India], July 27 (ANI): The Supreme Court on Monday asked Solicitor General Tushar Mehta what can be done to expedite the trials against the foreign nationals, who attended the Markaz Tablighi Jamaat congregation in Nizamuddin in March this year.
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
New Delhi [India], July 24 (ANI): The All India Institute of Medical Sciences (AIIMS) on Friday administered the first dose of country's first indigenous vaccine candidate `Covaxin' to a 30-year-old man as part of efforts to combat COVID-19.
New Delhi [India], July 22 (ANI): Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine.
Balasore (Odisha) [India], July 22 (ANI): Trials of Helicopter-launched Nag Missile anti-tank guided missile (HELINA), now named 'Dhruvastra', were conducted on July 15 and July 16 at Integrated Test Range (ITR) in Balasore.